Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015–2017 is a research paper published in PLOS ONE (2020). On theSindex it has a DataRank of 0.557. It has been cited 40 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.557
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Wellcome Trust
Grant: 098051
Wellcome Trust Sanger Institute - generic account for deposition of all core- funded research papers
Wellcome Trust
Grant: 090770
Resource centre for genomic epidemiology of malaria.
Wellcome Trust
Wellcome Trust
FWCI
4.28
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of A single point mutation in the Plasmodium falciparum 3′–5′ exonuclease does not alter piperaquine susceptibility
Additional file 1 of A single point mutation in the Plasmodium falciparum 3′–5′ exonuclease does not alter piperaquine susceptibility
Additional file 1 of Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South Sudan
Additional file 1 of Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South Sudan